메뉴 건너뛰기




Volumn 7, Issue 11, 2016, Pages 1452-1464

Proteomic upregulation of fatty acid synthase and fatty acid binding protein 5 and identification of cancer- and race-specific pathway associations in human prostate cancer tissues

Author keywords

Cytoskeletal proteins; Differential protein expression profiles; Extracellular matrix; Fatty acid metabolic process; Pathway analysis; Prostate cancer health disparity

Indexed keywords

AGRIN; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE FAMILY 1 MEMBER A3; AMYLOID PRECURSOR PROTEIN; CYTOSKELETON PROTEIN; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; FATTY ACID SYNTHASE; MEMBRANE PROTEIN; METASTASIS ASSOCIATED PROTEIN 3; PROTEIN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

EID: 84994338830     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.15860     Document Type: Article
Times cited : (39)

References (115)
  • 2
    • 0036138874 scopus 로고    scopus 로고
    • Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer
    • Meehan KL, Holland JW, Dawkins HJS. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate. 2002; 50: 54-63.
    • (2002) Prostate , vol.50 , pp. 54-63
    • Meehan, K.L.1    Holland, J.W.2    Dawkins, H.J.S.3
  • 3
    • 0037120949 scopus 로고    scopus 로고
    • Serum proteomic patterns for detection of prostate cancer
    • Petricoin EF, 3rd, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 2002; 94: 1576-1578.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 1576-1578
    • Petricoin, E.F.1    Ornstein, D.K.2    Paweletz, C.P.3
  • 4
    • 27644506613 scopus 로고    scopus 로고
    • Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
    • Varambally S, Yu J, Laxman B, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 2005; 8: 393-406.
    • (2005) Cancer Cell , vol.8 , pp. 393-406
    • Varambally, S.1    Yu, J.2    Laxman, B.3
  • 5
    • 36249025664 scopus 로고    scopus 로고
    • Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis
    • Lin J, Xu J, Tian H, et al. Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int J Cancer. 2007; 121: 2596-2605.
    • (2007) Int J Cancer , vol.121 , pp. 2596-2605
    • Lin, J.1    Xu, J.2    Tian, H.3
  • 6
    • 53049090352 scopus 로고    scopus 로고
    • Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry
    • Garbis SD, Tyritzis SI, Roumeliotis T, et al. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. J Proteome Res. 2008; 7: 3146-3158.
    • (2008) J Proteome Res , vol.7 , pp. 3146-3158
    • Garbis, S.D.1    Tyritzis, S.I.2    Roumeliotis, T.3
  • 7
    • 84862979866 scopus 로고    scopus 로고
    • Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel-and lectin-based proteomics analyses
    • Jayapalan JJ, Ng KL, Razack AH, et al. Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel-and lectin-based proteomics analyses. Electrophoresis. 2012; 33: 1855-1862.
    • (2012) Electrophoresis , vol.33 , pp. 1855-1862
    • Jayapalan, J.J.1    Ng, K.L.2    Razack, A.H.3
  • 8
    • 84857068469 scopus 로고    scopus 로고
    • iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer
    • Rehman I, Evans CA, Glen A, et al. iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer. PLoS One. 2012; 7: e30885.
    • (2012) PLoS One , vol.7
    • Rehman, I.1    Evans, C.A.2    Glen, A.3
  • 9
    • 84939176335 scopus 로고    scopus 로고
    • Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer
    • Davalieva K, Kostovska IM, Kiprijanovska S, et al. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer. Prostate. 2015; 75: 1586-1600.
    • (2015) Prostate , vol.75 , pp. 1586-1600
    • Davalieva, K.1    Kostovska, I.M.2    Kiprijanovska, S.3
  • 10
    • 18244392008 scopus 로고    scopus 로고
    • Proteomic analysis of human prostate cancer
    • Ahram M, Best CJM, Flaig MJ, et al. Proteomic analysis of human prostate cancer. Mol Carcinog. 2002; 33: 9-15.
    • (2002) Mol Carcinog , vol.33 , pp. 9-15
    • Ahram, M.1    Best, C.J.M.2    Flaig, M.J.3
  • 11
    • 51749123784 scopus 로고    scopus 로고
    • Apparently low reproducibility of true differential expression discoveries in microarray studies
    • Zhang M, Yao C, Guo Z, et al. Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics. 2008; 24: 2057-2063.
    • (2008) Bioinformatics , vol.24 , pp. 2057-2063
    • Zhang, M.1    Yao, C.2    Guo, Z.3
  • 12
    • 84873340345 scopus 로고    scopus 로고
    • Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data
    • Chen J, Wang Y, Shen B, et al. Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data. Comput Math Methods Med. 2013; 2013: 909525.
    • (2013) Comput Math Methods Med , vol.2013
    • Chen, J.1    Wang, Y.2    Shen, B.3
  • 13
    • 0036682376 scopus 로고    scopus 로고
    • Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer
    • Rhodes DR, Barrette TR, Rubin MA, et al. Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 2002; 62: 4427-4433.
    • (2002) Cancer Res , vol.62 , pp. 4427-4433
    • Rhodes, D.R.1    Barrette, T.R.2    Rubin, M.A.3
  • 14
    • 26444608611 scopus 로고    scopus 로고
    • Discovering statistically significant pathways in expression profiling studies
    • Tian L, Greenberg SA, Kong SW, et al. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A. 2005; 102: 13544-13549.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 13544-13549
    • Tian, L.1    Greenberg, S.A.2    Kong, S.W.3
  • 15
    • 33749999763 scopus 로고    scopus 로고
    • Group testing for pathway analysis improves comparability of different microarray datasets
    • Manoli T, Gretz N, Gröne H, et al. Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics. 2006; 22: 2500-2506.
    • (2006) Bioinformatics , vol.22 , pp. 2500-2506
    • Manoli, T.1    Gretz, N.2    Gröne, H.3
  • 16
    • 57149092133 scopus 로고    scopus 로고
    • Inferring pathway activity toward precise disease classification
    • Lee E, Chuang HY, Kim JW, et al. Inferring pathway activity toward precise disease classification. PLoS Comput Biol. 2008; 4: e1000217.
    • (2008) PLoS Comput Biol , vol.4
    • Lee, E.1    Chuang, H.Y.2    Kim, J.W.3
  • 17
    • 79959713125 scopus 로고    scopus 로고
    • Identifying novel prostate cancer associated pathways based on integrative microarray data analysis
    • Wang Y, Chen J, Li Q, et al. Identifying novel prostate cancer associated pathways based on integrative microarray data analysis. Comput Biol Chem. 2011; 35: 151-158.
    • (2011) Comput Biol Chem , vol.35 , pp. 151-158
    • Wang, Y.1    Chen, J.2    Li, Q.3
  • 18
    • 52149123619 scopus 로고    scopus 로고
    • Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
    • Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008; 321: 1801-1806.
    • (2008) Science , vol.321 , pp. 1801-1806
    • Jones, S.1    Zhang, X.2    Parsons, D.W.3
  • 19
    • 0003677259 scopus 로고    scopus 로고
    • Atlanta: American Cancer Society
    • American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
    • (2015) Cancer facts & figures 2015
  • 20
    • 0031984026 scopus 로고    scopus 로고
    • Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12
    • Vijayakumar S, Winter K, Sause W, et al. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12. Int J Radiat Oncol Biol Phys. 1998; 40: 17-25.
    • (1998) Int J Radiat Oncol Biol Phys , vol.40 , pp. 17-25
    • Vijayakumar, S.1    Winter, K.2    Sause, W.3
  • 21
    • 84892415984 scopus 로고    scopus 로고
    • Age and racial differences among PSA-detected (AJCC stage T1cN0M0) prostate cancer in the U.S.: A population-based study of 70,345 men
    • Zhang H, Messing EM, Travis LB, et al. Age and racial differences among PSA-detected (AJCC stage T1cN0M0) prostate cancer in the U.S.: A population-based study of 70,345 men. Front Oncol. 2013; 3: 312.
    • (2013) Front Oncol , vol.3 , pp. 312
    • Zhang, H.1    Messing, E.M.2    Travis, L.B.3
  • 22
    • 0028865113 scopus 로고
    • Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
    • Moul JW, Sesterhenn IA, Connelly RR, et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 1995; 274: 1277-1281.
    • (1995) JAMA , vol.274 , pp. 1277-1281
    • Moul, J.W.1    Sesterhenn, I.A.2    Connelly, R.R.3
  • 23
    • 0032323805 scopus 로고    scopus 로고
    • Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens
    • Pettaway CA, Troncoso P, Ramirez EI, et al. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens. J Urol. 1998; 160: 437-442.
    • (1998) J Urol , vol.160 , pp. 437-442
    • Pettaway, C.A.1    Troncoso, P.2    Ramirez, E.I.3
  • 24
    • 77950519549 scopus 로고    scopus 로고
    • Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity
    • Powell IJ, Bock CH, Ruterbusch JJ, et al. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010; 183: 1792-1797.
    • (2010) J Urol , vol.183 , pp. 1792-1797
    • Powell, I.J.1    Bock, C.H.2    Ruterbusch, J.J.3
  • 25
    • 84924290869 scopus 로고    scopus 로고
    • Predominance of ERG-negative high-grade prostate cancers in African American men
    • Farrell J, Young D, Chen Y, et al. Predominance of ERG-negative high-grade prostate cancers in African American men. Mol Clin Oncol. 2014; 2: 982-986.
    • (2014) Mol Clin Oncol , vol.2 , pp. 982-986
    • Farrell, J.1    Young, D.2    Chen, Y.3
  • 26
    • 0035819936 scopus 로고    scopus 로고
    • Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study
    • Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst. 2001; 93: 388-395.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 388-395
    • Hoffman, R.M.1    Gilliland, F.D.2    Eley, J.W.3
  • 27
    • 84873745349 scopus 로고    scopus 로고
    • African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke prostate center
    • Tsivian M, Banez LL, Keto CJ, et al. African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke prostate center. Prostate Cancer Prostatic Dis. 2013; 16: 91-94.
    • (2013) Prostate Cancer Prostatic Dis , vol.16 , pp. 91-94
    • Tsivian, M.1    Banez, L.L.2    Keto, C.J.3
  • 28
    • 33745315223 scopus 로고    scopus 로고
    • African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men
    • Sanchez-Ortiz RF, Troncoso P, Babaian RJ, et al. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer. 2006; 107: 75-82.
    • (2006) Cancer , vol.107 , pp. 75-82
    • Sanchez-Ortiz, R.F.1    Troncoso, P.2    Babaian, R.J.3
  • 29
    • 84924542708 scopus 로고    scopus 로고
    • African-American race is a predictor of seminal vesicle invasion after radical prostatectomy
    • Yamoah K, Walker A, Spangler E, et al. African-American race is a predictor of seminal vesicle invasion after radical prostatectomy. Clin Genitourin Cancer. 2015; 13: e65-72.
    • (2015) Clin Genitourin Cancer , vol.13 , pp. e65-e72
    • Yamoah, K.1    Walker, A.2    Spangler, E.3
  • 30
    • 84923328574 scopus 로고    scopus 로고
    • African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men
    • Yamoah K, Deville C, Vapiwala N, et al. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol. 2015; 33: 70.e15-70.e22.
    • (2015) Urol Oncol , vol.33 , pp. 70.e15-70.e22
    • Yamoah, K.1    Deville, C.2    Vapiwala, N.3
  • 31
    • 84880803870 scopus 로고    scopus 로고
    • Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men
    • Farrell J, Petrovics G, McLeod DG, et al. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. Int J Mol Sci. 2013; 14: 15510-15531.
    • (2013) Int J Mol Sci , vol.14 , pp. 15510-15531
    • Farrell, J.1    Petrovics, G.2    McLeod, D.G.3
  • 32
    • 84885949199 scopus 로고    scopus 로고
    • Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes
    • Kinseth MA, Jia Z, Rahmatpanah F, et al. Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes. Int J Cancer. 2013; 134: 81-91.
    • (2013) Int J Cancer , vol.134 , pp. 81-91
    • Kinseth, M.A.1    Jia, Z.2    Rahmatpanah, F.3
  • 33
    • 84877936647 scopus 로고    scopus 로고
    • Genes associated with prostate cancer are differentially expressed in African American and European American men
    • Powell IJ, Dyson G, Land S, et al. Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomarkers Prev. 2013; 22: 891-897.
    • (2013) Cancer Epidemiol Biomarkers Prev , vol.22 , pp. 891-897
    • Powell, I.J.1    Dyson, G.2    Land, S.3
  • 34
    • 60349099540 scopus 로고    scopus 로고
    • Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: A pilot project study
    • Reams RR, Agrawal D, Davis MB, et al. Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: A pilot project study. Infect Agent Cancer. 2009; 4: S3.
    • (2009) Infect Agent Cancer , vol.4 , pp. S3
    • Reams, R.R.1    Agrawal, D.2    Davis, M.B.3
  • 35
    • 85040379615 scopus 로고    scopus 로고
    • Differentially expressed genes in tumors of prostate cancer in American patients with European and African origin
    • Venkatesh K, Lajwanti D, Kiran SP, et al. Differentially expressed genes in tumors of prostate cancer in American patients with European and African origin. J Pharm Res. 2013; 6: 583-588.
    • (2013) J Pharm Res , vol.6 , pp. 583-588
    • Venkatesh, K.1    Lajwanti, D.2    Kiran, S.P.3
  • 36
    • 84877889086 scopus 로고    scopus 로고
    • Androgen receptor-target genes in African American prostate cancer disparities
    • Wang BD, Yang Q, Ceniccola K, et al. Androgen receptor-target genes in African American prostate cancer disparities. Prostate Cancer. 2013; 2013: 763569.
    • (2013) Prostate Cancer , vol.2013
    • Wang, B.D.1    Yang, Q.2    Ceniccola, K.3
  • 37
    • 38849190111 scopus 로고    scopus 로고
    • Tumor immunobiological differences in prostate cancer between African-American and European-American men
    • Wallace TA, Prueitt RL, Yi M, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008; 68: 927-936.
    • (2008) Cancer Res , vol.68 , pp. 927-936
    • Wallace, T.A.1    Prueitt, R.L.2    Yi, M.3
  • 38
    • 0037498543 scopus 로고    scopus 로고
    • Black-white differences in survival from late-stage prostate cancer
    • Polednak AP. Black-white differences in survival from late-stage prostate cancer. Ethn Dis. 2003; 13: 220-225.
    • (2003) Ethn Dis , vol.13 , pp. 220-225
    • Polednak, A.P.1
  • 39
    • 77951808916 scopus 로고    scopus 로고
    • Racial differences in prostate cancer risk remain among US servicemen with equal access to care
    • Wells TS, Bukowinski AT, Smith TC, et al. Racial differences in prostate cancer risk remain among US servicemen with equal access to care. Prostate. 2010; 70: 727-734.
    • (2010) Prostate , vol.70 , pp. 727-734
    • Wells, T.S.1    Bukowinski, A.T.2    Smith, T.C.3
  • 40
    • 0345530846 scopus 로고    scopus 로고
    • Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer
    • Godley PA, Schenck AP, Amamoo MA, et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst. 2003; 95: 1702-1710.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 1702-1710
    • Godley, P.A.1    Schenck, A.P.2    Amamoo, M.A.3
  • 41
    • 84956945828 scopus 로고    scopus 로고
    • Differentially expressed genes and signature pathways of human prostate cancer
    • Myers JS, von Lersner AK, Robbins CJ, et al. Differentially expressed genes and signature pathways of human prostate cancer. PLoS One. 2015; 10: e0145322.
    • (2015) PLoS One , vol.10
    • Myers, J.S.1    von Lersner, A.K.2    Robbins, C.J.3
  • 42
    • 84912122995 scopus 로고    scopus 로고
    • Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between white (non-Hispanic) and African-American groups
    • Zaman N, Giannopoulos PN, Chowdhury S, et al. Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between white (non-Hispanic) and African-American groups. PLoS One. 2014; 9: e113190.
    • (2014) PLoS One , vol.9
    • Zaman, N.1    Giannopoulos, P.N.2    Chowdhury, S.3
  • 43
    • 84896445317 scopus 로고    scopus 로고
    • Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens
    • Libes JM, Seeley EH, Li M, et al. Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens. J Am Coll Surg. 2014; 218: 707-720.
    • (2014) J Am Coll Surg , vol.218 , pp. 707-720
    • Libes, J.M.1    Seeley, E.H.2    Li, M.3
  • 44
    • 84884733974 scopus 로고    scopus 로고
    • Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity
    • Dillon ST, Bhasin MK, Feng X, et al. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J Transl Med. 2013; 11: 239-5876-11-239.
    • (2013) J Transl Med , vol.11
    • Dillon, S.T.1    Bhasin, M.K.2    Feng, X.3
  • 45
    • 67349266694 scopus 로고    scopus 로고
    • Universal sample preparation method for proteome analysis
    • Wisniewski JR, Zougman A, Nagaraj N, et al. Universal sample preparation method for proteome analysis. Nat Methods. 2009; 6: 359-362.
    • (2009) Nat Methods , vol.6 , pp. 359-362
    • Wisniewski, J.R.1    Zougman, A.2    Nagaraj, N.3
  • 47
    • 84874969184 scopus 로고    scopus 로고
    • PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees
    • Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2013; 41: D377-D386.
    • (2013) Nucleic Acids Res , vol.41 , pp. D377-D386
    • Mi, H.1    Muruganujan, A.2    Thomas, P.D.3
  • 48
    • 27344435774 scopus 로고    scopus 로고
    • Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
    • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102: 15545-15550.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 15545-15550
    • Subramanian, A.1    Tamayo, P.2    Mootha, V.K.3
  • 49
    • 58049215467 scopus 로고    scopus 로고
    • A novel signaling pathway impact analysis
    • Tarca AL, Draghici S, Khatri P, et al. A novel signaling pathway impact analysis. Bioinformatics. 2009; 25: 75-82.
    • (2009) Bioinformatics , vol.25 , pp. 75-82
    • Tarca, A.L.1    Draghici, S.2    Khatri, P.3
  • 50
    • 84878855445 scopus 로고    scopus 로고
    • Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer
    • Jia P, Liu Y, Zhao Z. Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer. BMC Syst Biol. 2012; 6 Suppl 3: S3-S13.
    • (2012) BMC Syst Biol , vol.6 , pp. S3-S13
    • Jia, P.1    Liu, Y.2    Zhao, Z.3
  • 51
    • 44349119764 scopus 로고    scopus 로고
    • Gene network and canonical pathway analysis in prostate cancer: A microarray study
    • Savli H, Szendroi A, Romics I, et al. Gene network and canonical pathway analysis in prostate cancer: A microarray study. Exp Mol Med. 2008; 40: 176-185.
    • (2008) Exp Mol Med , vol.40 , pp. 176-185
    • Savli, H.1    Szendroi, A.2    Romics, I.3
  • 52
    • 67049157979 scopus 로고    scopus 로고
    • Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures
    • Grubb RL, Deng J, Pinto PA, et al. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res. 2009; 8: 3044-3054.
    • (2009) J Proteome Res , vol.8 , pp. 3044-3054
    • Grubb, R.L.1    Deng, J.2    Pinto, P.A.3
  • 53
    • 33645114908 scopus 로고    scopus 로고
    • Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
    • Shah US, Dhir R, Gollin SM, et al. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol. 2006; 37: 401-409.
    • (2006) Hum Pathol , vol.37 , pp. 401-409
    • Shah, U.S.1    Dhir, R.2    Gollin, S.M.3
  • 54
    • 4344707340 scopus 로고    scopus 로고
    • Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs
    • Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res. 2004; 64: 5963-5972.
    • (2004) Cancer Res , vol.64 , pp. 5963-5972
    • Ashida, S.1    Nakagawa, H.2    Katagiri, T.3
  • 55
    • 0042429210 scopus 로고    scopus 로고
    • Fatty acid synthase expression defines distinct molecular signatures in prostate cancer
    • Rossi S, Graner E, Febbo P, et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res. 2003; 1: 707-715.
    • (2003) Mol Cancer Res , vol.1 , pp. 707-715
    • Rossi, S.1    Graner, E.2    Febbo, P.3
  • 56
    • 0036497907 scopus 로고    scopus 로고
    • Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
    • Swinnen JV, Roskams T, Joniau S, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer. 2002; 98: 19-22.
    • (2002) Int J Cancer , vol.98 , pp. 19-22
    • Swinnen, J.V.1    Roskams, T.2    Joniau, S.3
  • 58
    • 84963938401 scopus 로고    scopus 로고
    • Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
    • [Epub ahead of print].
    • Wen S, Niu Y, Lee SO, et al. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells. Mol Carcinog. 2016; [Epub ahead of print].
    • (2016) Mol Carcinog
    • Wen, S.1    Niu, Y.2    Lee, S.O.3
  • 59
    • 63649099458 scopus 로고    scopus 로고
    • Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer
    • Migita T, Ruiz S, Fornari A, et al. Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst. 2009; 101: 519-532.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 519-532
    • Migita, T.1    Ruiz, S.2    Fornari, A.3
  • 60
    • 44949244988 scopus 로고    scopus 로고
    • The pathogenesis of prostate cancer: From molecular to metabolic alterations
    • Benedettini E, Nguyen P, Loda M. The pathogenesis of prostate cancer: From molecular to metabolic alterations. Diagn Histopathol. 2008; 14: 195-201.
    • (2008) Diagn Histopathol , vol.14 , pp. 195-201
    • Benedettini, E.1    Nguyen, P.2    Loda, M.3
  • 61
    • 84958555054 scopus 로고    scopus 로고
    • The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis
    • Kawaguchi K, Kinameri A, Suzuki S, et al. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis. Biochem J. 2016; 473: 449-461.
    • (2016) Biochem J , vol.473 , pp. 449-461
    • Kawaguchi, K.1    Kinameri, A.2    Suzuki, S.3
  • 62
    • 44449096722 scopus 로고    scopus 로고
    • Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression
    • Morgan EA, Forootan SS, Adamson J, et al. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression. Int J Oncol. 2008; 32: 767-775.
    • (2008) Int J Oncol , vol.32 , pp. 767-775
    • Morgan, E.A.1    Forootan, S.S.2    Adamson, J.3
  • 63
    • 0037951788 scopus 로고    scopus 로고
    • High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity
    • Adamson J, Morgan EA, Beesley C, et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene. 2003; 22: 2739-2749.
    • (2003) Oncogene , vol.22 , pp. 2739-2749
    • Adamson, J.1    Morgan, E.A.2    Beesley, C.3
  • 64
    • 50949128339 scopus 로고    scopus 로고
    • The emerging functions and mechanisms of mammalian fatty acid-binding proteins
    • Storch J, Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr. 2008; 28: 73-95.
    • (2008) Annu Rev Nutr , vol.28 , pp. 73-95
    • Storch, J.1    Corsico, B.2
  • 65
    • 0036291635 scopus 로고    scopus 로고
    • Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription
    • Tan N-, Shaw NS, Vinckenbosch N, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol. 2002; 22: 5114-5127.
    • (2002) Mol Cell Biol , vol.22 , pp. 5114-5127
    • Tan, N.1    Shaw, N.S.2    Vinckenbosch, N.3
  • 66
    • 84887425280 scopus 로고    scopus 로고
    • A novel cutaneous fatty acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells
    • Bao Z, Malki MI, Forootan SS, et al. A novel cutaneous fatty acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells. Genes Cancer. 2013; 4: 297-314.
    • (2013) Genes Cancer , vol.4 , pp. 297-314
    • Bao, Z.1    Malki, M.I.2    Forootan, S.S.3
  • 67
    • 84891907019 scopus 로고    scopus 로고
    • The expression of C-FABP and PPARgamma and their prognostic significance in prostate cancer
    • Forootan FS, Forootan SS, Malki MI, et al. The expression of C-FABP and PPARgamma and their prognostic significance in prostate cancer. Int J Oncol. 2014; 44: 265-275.
    • (2014) Int J Oncol , vol.44 , pp. 265-275
    • Forootan, F.S.1    Forootan, S.S.2    Malki, M.I.3
  • 68
    • 77956866143 scopus 로고    scopus 로고
    • Involvement of fatty acid binding protein 5 and PPARbeta/delta in prostate cancer cell growth
    • Morgan E, Kannan-Thulasiraman P, Noy N. Involvement of fatty acid binding protein 5 and PPARbeta/delta in prostate cancer cell growth. PPAR Res. 2010; 2010: 234629.
    • (2010) PPAR Res , vol.2010
    • Morgan, E.1    Kannan-Thulasiraman, P.2    Noy, N.3
  • 69
    • 73649114942 scopus 로고    scopus 로고
    • Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis
    • Pang J, Liu WP, Liu XP, et al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res. 2010; 9: 216-226.
    • (2010) J Proteome Res , vol.9 , pp. 216-226
    • Pang, J.1    Liu, W.P.2    Liu, X.P.3
  • 70
    • 0035360281 scopus 로고    scopus 로고
    • Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells
    • Jing C, Beesley C, Foster CS, et al. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res. 2001; 61: 4357-4364.
    • (2001) Cancer Res , vol.61 , pp. 4357-4364
    • Jing, C.1    Beesley, C.2    Foster, C.S.3
  • 71
    • 0034051501 scopus 로고    scopus 로고
    • Coordinate expression of cytokeratins 7and 20 in prostate adenocarcinoma and bladder urothelial carcinoma
    • Bassily NH, Vallorosi CJ, Akdas G, et al. Coordinate expression of cytokeratins 7and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol. 2000; 113: 383-388.
    • (2000) Am J Clin Pathol , vol.113 , pp. 383-388
    • Bassily, N.H.1    Vallorosi, C.J.2    Akdas, G.3
  • 72
    • 0033711090 scopus 로고    scopus 로고
    • Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma
    • Genega EM, Hutchinson B, Reuter VE, et al. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol. 2000; 13: 1186-1191.
    • (2000) Mod Pathol , vol.13 , pp. 1186-1191
    • Genega, E.M.1    Hutchinson, B.2    Reuter, V.E.3
  • 73
    • 0029013612 scopus 로고
    • Coordinate expression of cytokeratins 7 and 20defines unique subsets of carcinomas
    • Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20defines unique subsets of carcinomas. Appl Immunohistochemistry. 1995; 3: 99-107.
    • (1995) Appl Immunohistochemistry , vol.3 , pp. 99-107
    • Wang, N.P.1    Zee, S.2    Zarbo, R.J.3
  • 74
    • 0028799310 scopus 로고
    • Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate
    • Heatley M, Maxwell P, Whiteside C, et al. Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate. J Clin Pathol. 1995; 48: 1031-1034.
    • (1995) J Clin Pathol , vol.48 , pp. 1031-1034
    • Heatley, M.1    Maxwell, P.2    Whiteside, C.3
  • 75
    • 0033795923 scopus 로고    scopus 로고
    • Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases
    • Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol. 2000; 13: 962-972.
    • (2000) Mod Pathol , vol.13 , pp. 962-972
    • Chu, P.1    Wu, E.2    Weiss, L.M.3
  • 76
    • 0036127901 scopus 로고    scopus 로고
    • Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores
    • Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol. 2002; 117: 471-477.
    • (2002) Am J Clin Pathol , vol.117 , pp. 471-477
    • Goldstein, N.S.1
  • 77
    • 0036206309 scopus 로고    scopus 로고
    • Cytokeratins 20 and 7 as biomarkers: Usefulness in discriminating primary from metastatic adenocarcinoma
    • Tot T. Cytokeratins 20 and 7 as biomarkers: Usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 2002; 38: 758-763.
    • (2002) Eur J Cancer , vol.38 , pp. 758-763
    • Tot, T.1
  • 78
    • 0026672669 scopus 로고
    • Keratin profiles in normal/hyperplastic prostates and prostate carcinoma
    • Okada H, Tsubura A, Okamura A, et al. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat Histopathol. 1992; 421: 157-161.
    • (1992) Virchows Arch A Pathol Anat Histopathol , vol.421 , pp. 157-161
    • Okada, H.1    Tsubura, A.2    Okamura, A.3
  • 79
    • 0025177164 scopus 로고
    • Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate
    • Sherwood ER, Berg LA, Mitchell NJ, et al. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol. 1990; 143: 167-171.
    • (1990) J Urol , vol.143 , pp. 167-171
    • Sherwood, E.R.1    Berg, L.A.2    Mitchell, N.J.3
  • 80
    • 77955084824 scopus 로고    scopus 로고
    • Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma
    • Korita PV, Wakai T, Ajioka Y, et al. Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma. Anticancer Res. 2010; 30: 2279-2285.
    • (2010) Anticancer Res , vol.30 , pp. 2279-2285
    • Korita, P.V.1    Wakai, T.2    Ajioka, Y.3
  • 81
    • 84872200824 scopus 로고    scopus 로고
    • Early events in cell adhesion and polarity during epithelial-mesenchymal transition
    • Huang RY, Guilford P, Thiery JP. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci. 2012; 125: 4417-4422.
    • (2012) J Cell Sci , vol.125 , pp. 4417-4422
    • Huang, R.Y.1    Guilford, P.2    Thiery, J.P.3
  • 82
    • 84927129326 scopus 로고    scopus 로고
    • The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia
    • Xiao Y, Zhou Y, Chen Y, et al. The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia. Pediatr Res. 2015; 77: 310-315.
    • (2015) Pediatr Res , vol.77 , pp. 310-315
    • Xiao, Y.1    Zhou, Y.2    Chen, Y.3
  • 83
    • 84963705448 scopus 로고    scopus 로고
    • ALDH1A3, a metabolic target for cancer diagnosis and therapy
    • [Epub ahead of print].
    • Duan J, Cai J, Guo Y, et al. ALDH1A3, a metabolic target for cancer diagnosis and therapy. Int J Cancer. 2016; [Epub ahead of print].
    • (2016) Int J Cancer
    • Duan, J.1    Cai, J.2    Guo, Y.3
  • 84
    • 84929379752 scopus 로고    scopus 로고
    • MiR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer
    • Casanova-Salas I, Masia E, Arminan A, et al. MiR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer. PLoS One. 2015; 10: e0125576.
    • (2015) PLoS One , vol.10
    • Casanova-Salas, I.1    Masia, E.2    Arminan, A.3
  • 85
    • 34249687656 scopus 로고    scopus 로고
    • Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP
    • Trasino SE, Harrison EH, Wang TT. Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP. Exp Biol Med. 2007; 232: 762-771.
    • (2007) Exp Biol Med , vol.232 , pp. 762-771
    • Trasino, S.E.1    Harrison, E.H.2    Wang, T.T.3
  • 86
    • 84905514443 scopus 로고    scopus 로고
    • Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway
    • Shao C, Sullivan JP, Girard L, et al. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Clin Cancer Res. 2014; 20: 4154-4166.
    • (2014) Clin Cancer Res , vol.20 , pp. 4154-4166
    • Shao, C.1    Sullivan, J.P.2    Girard, L.3
  • 87
    • 84866671365 scopus 로고    scopus 로고
    • ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets
    • Luo Y, Dallaglio K, Chen Y, et al. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012; 30: 2100-2113.
    • (2012) Stem Cells , vol.30 , pp. 2100-2113
    • Luo, Y.1    Dallaglio, K.2    Chen, Y.3
  • 88
    • 79951818699 scopus 로고    scopus 로고
    • Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis
    • Marcato P, Dean CA, Pan D, et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells. 2011; 29: 32-45.
    • (2011) Stem Cells , vol.29 , pp. 32-45
    • Marcato, P.1    Dean, C.A.2    Pan, D.3
  • 89
    • 57349114162 scopus 로고    scopus 로고
    • The cell-cell adhesion molecule E-cadherin
    • van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008; 65: 3756-3788.
    • (2008) Cell Mol Life Sci , vol.65 , pp. 3756-3788
    • van Roy, F.1    Berx, G.2
  • 90
    • 0026795845 scopus 로고
    • Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
    • Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992; 52: 5104-5109.
    • (1992) Cancer Res , vol.52 , pp. 5104-5109
    • Umbas, R.1    Schalken, J.A.2    Aalders, T.W.3
  • 91
    • 0033744070 scopus 로고    scopus 로고
    • Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens
    • Wang J, Krill D, Torbenson M, et al. Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens. Urol Res. 2000; 28: 308-315.
    • (2000) Urol Res , vol.28 , pp. 308-315
    • Wang, J.1    Krill, D.2    Torbenson, M.3
  • 92
    • 77649132876 scopus 로고    scopus 로고
    • E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer
    • Pontes J, Jr, Srougi M, Borra PM, et al. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer. Appl Immunohistochem Mol Morphol. 2010; 18: 179-184.
    • (2010) Appl Immunohistochem Mol Morphol , vol.18 , pp. 179-184
    • Pontes, J.1    Srougi, M.2    Borra, P.M.3
  • 93
    • 0032324792 scopus 로고    scopus 로고
    • Analysis of cathepsin D forms and their clinical implications in human prostate cancer
    • Cherry JP, Mordente JA, Chapman JR, et al. Analysis of cathepsin D forms and their clinical implications in human prostate cancer. J Urol. 1998; 160: 2223-2228.
    • (1998) J Urol , vol.160 , pp. 2223-2228
    • Cherry, J.P.1    Mordente, J.A.2    Chapman, J.R.3
  • 94
    • 77957001036 scopus 로고    scopus 로고
    • Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer
    • El Melegy NT, Aboulella HA, Abul-Fadl AM, et al. Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer. Br J Biomed Sci. 2010; 67: 109-112.
    • (2010) Br J Biomed Sci , vol.67 , pp. 109-112
    • El Melegy, N.T.1    Aboulella, H.A.2    Abul-Fadl, A.M.3
  • 95
    • 0036834245 scopus 로고    scopus 로고
    • Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression
    • Hara I, Miyake H, Yamanaka K, et al. Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression. Oncol Rep. 2002; 9: 1379-1383.
    • (2002) Oncol Rep , vol.9 , pp. 1379-1383
    • Hara, I.1    Miyake, H.2    Yamanaka, K.3
  • 96
    • 84875126913 scopus 로고    scopus 로고
    • Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium
    • Pruitt FL, He Y, Franco OE, et al. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. Prostate. 2013; 73: 476-488.
    • (2013) Prostate , vol.73 , pp. 476-488
    • Pruitt, F.L.1    He, Y.2    Franco, O.E.3
  • 97
    • 0037453706 scopus 로고    scopus 로고
    • MTA3, a mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer
    • Fujita N, Jaye DL, Kajita M, et al. MTA3, a mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003; 113: 207-219.
    • (2003) Cell , vol.113 , pp. 207-219
    • Fujita, N.1    Jaye, D.L.2    Kajita, M.3
  • 98
    • 0024805872 scopus 로고
    • Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer
    • Rochefort H, Cavailles V, Augereau P, et al. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem. 1989; 34: 177-182.
    • (1989) J Steroid Biochem , vol.34 , pp. 177-182
    • Rochefort, H.1    Cavailles, V.2    Augereau, P.3
  • 99
    • 84914150699 scopus 로고    scopus 로고
    • MTA family of proteins in prostate cancer: Biology, significance, and therapeutic opportunities
    • Levenson AS, Kumar A, Zhang X. MTA family of proteins in prostate cancer: Biology, significance, and therapeutic opportunities. Cancer Metastasis Rev. 2014; 33: 929-942.
    • (2014) Cancer Metastasis Rev , vol.33 , pp. 929-942
    • Levenson, A.S.1    Kumar, A.2    Zhang, X.3
  • 100
    • 0030271572 scopus 로고    scopus 로고
    • Macromolecular organization of basement membranes
    • Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol. 1996; 8: 618-624.
    • (1996) Curr Opin Cell Biol , vol.8 , pp. 618-624
    • Timpl, R.1
  • 101
    • 0034075654 scopus 로고    scopus 로고
    • Form and function: The laminin family of heterotrimers
    • Colognato H, Yurchenco PD. Form and function: The laminin family of heterotrimers. Dev Dyn. 2000; 218: 213-234.
    • (2000) Dev Dyn , vol.218 , pp. 213-234
    • Colognato, H.1    Yurchenco, P.D.2
  • 102
    • 72949119124 scopus 로고    scopus 로고
    • Integrins in cancer: Biological implications and therapeutic opportunities
    • Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer. 2010; 10: 9-22.
    • (2010) Nat Rev Cancer , vol.10 , pp. 9-22
    • Desgrosellier, J.S.1    Cheresh, D.A.2
  • 103
    • 53849143245 scopus 로고    scopus 로고
    • Integrins in prostate cancer progression
    • Goel HL, Li J, Kogan S, et al. Integrins in prostate cancer progression. Endocr Relat Cancer. 2008; 15: 657-664.
    • (2008) Endocr Relat Cancer , vol.15 , pp. 657-664
    • Goel, H.L.1    Li, J.2    Kogan, S.3
  • 104
    • 77949862490 scopus 로고    scopus 로고
    • The final steps of integrin activation: The end game
    • Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: The end game. Nat Rev Mol Cell Biol. 2010; 11: 288-300.
    • (2010) Nat Rev Mol Cell Biol , vol.11 , pp. 288-300
    • Shattil, S.J.1    Kim, C.2    Ginsberg, M.H.3
  • 105
    • 84873385587 scopus 로고    scopus 로고
    • Integrin signaling in cancer cell survival and chemoresistance
    • Aoudjit F, Vuori K. Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract. 2012; 2012: 283181.
    • (2012) Chemother Res Pract , vol.2012
    • Aoudjit, F.1    Vuori, K.2
  • 106
    • 0027935370 scopus 로고
    • Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma
    • Nagle RB, Knox JD, Wolf C, et al. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl. 1994; 19: 232-237.
    • (1994) J Cell Biochem Suppl , vol.19 , pp. 232-237
    • Nagle, R.B.1    Knox, J.D.2    Wolf, C.3
  • 107
    • 0028200873 scopus 로고
    • Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate
    • Knox JD, Cress AE, Clark V, et al. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol. 1994; 145: 167-174.
    • (1994) Am J Pathol , vol.145 , pp. 167-174
    • Knox, J.D.1    Cress, A.E.2    Clark, V.3
  • 108
    • 2642682426 scopus 로고    scopus 로고
    • In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: Increased basement membrane gene expression in high-grade and metastatic lesions
    • Pföhler C, Fixemer T, Jung V, et al. In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: Increased basement membrane gene expression in high-grade and metastatic lesions. Prostate. 1998; 36: 143-150.
    • (1998) Prostate , vol.36 , pp. 143-150
    • Pföhler, C.1    Fixemer, T.2    Jung, V.3
  • 109
    • 0030796362 scopus 로고    scopus 로고
    • Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas
    • Dehan P, Waltregny D, Beschin A, et al. Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. Am J Pathol. 1997; 151: 1097-1104.
    • (1997) Am J Pathol , vol.151 , pp. 1097-1104
    • Dehan, P.1    Waltregny, D.2    Beschin, A.3
  • 111
    • 84879952909 scopus 로고    scopus 로고
    • Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis
    • Varisli L. Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis. Genet Test Mol Biomarkers. 2013; 17: 562-566.
    • (2013) Genet Test Mol Biomarkers , vol.17 , pp. 562-566
    • Varisli, L.1
  • 112
    • 0027537092 scopus 로고
    • Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands
    • Bonkhoff H, Stein U, Remberger K. Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol. 1993; 24: 243-248.
    • (1993) Hum Pathol , vol.24 , pp. 243-248
    • Bonkhoff, H.1    Stein, U.2    Remberger, K.3
  • 113
    • 0028973409 scopus 로고
    • The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression
    • Cress AE, Rabinovitz I, Zhu W, et al. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev. 1995; 14: 219-228.
    • (1995) Cancer Metastasis Rev , vol.14 , pp. 219-228
    • Cress, A.E.1    Rabinovitz, I.2    Zhu, W.3
  • 114
    • 0029024897 scopus 로고
    • Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue
    • Nagle RB, Hao J, Knox JD, et al. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol. 1995; 146: 1498-1507.
    • (1995) Am J Pathol , vol.146 , pp. 1498-1507
    • Nagle, R.B.1    Hao, J.2    Knox, J.D.3
  • 115
    • 84876586639 scopus 로고    scopus 로고
    • Targeting constitutively activated beta1 integrins inhibits prostate cancer metastasis
    • Lee YC, Jin JK, Cheng CJ, et al. Targeting constitutively activated beta1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013; 11: 405-417.
    • (2013) Mol Cancer Res , vol.11 , pp. 405-417
    • Lee, Y.C.1    Jin, J.K.2    Cheng, C.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.